Of interest, we found that these glioma-associated microglia were nearly threefold higher in the IL-33-expressing xenografts than the control (Fig. 10c), an observation supporting IL-33 as a driver of an activated glioma microenvironment. This evidence concerns the gene IL33 and central nervous system cancer.